Back to Journals » OncoTargets and Therapy » Volume 6

Nimotuzumab as a radiosensitizing agent in the treatment of high grade glioma: challenges and opportunities

Total article views   HTML views PDF downloads Totals
10,984 Dovepress* 8,488+ 1,756 10,244
PubMed Central* 2,496 1,204 3,700
Totals 10,984 2,960 13,944
*Since 24 July 2013
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar